(Q35105263)

6 August 2017

1 reference

title

Impact of prebiotics and probiotics on skin health (English)

1 reference

6 August 2017

0 references

F H Al-Ghazzewi

1

1 reference

6 August 2017

R F Tester

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

99-107

1 reference

Actions of gluco-oligosaccharide against Staphylococcus aureus

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Comparative genomics and transcriptomics of Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

21 January 2018

Probiotics and the skin.

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Advances in management of atopic dermatitis: new therapies and novel uses of existing treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Suppression of proinflammatory cytokine production by specific metabolites of Lactobacillus plantarum 10hk2 via inhibiting NF-κB and p38 MAPK expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Skin microbiota: a source of disease or defence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Bacterial community variation in human body habitats across space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Topographic diversity of fungal and bacterial communities in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Microbial ecology of human skin in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Microbial symbiosis with the innate immune defense system of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Acute skin barrier disruption with repeated tape stripping: an in vivo model for damage skin barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Quantitation of major human cutaneous bacterial and fungal populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Topographical and temporal diversity of the human skin microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics for photoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Skin microbiome: looking back to move forward.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

How long do nosocomial pathogens persist on inanimate surfaces? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Pre- and probiotics for human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotic bacteria induce a 'glow of health'

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics and atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics: an emerging therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Shifts in human skin and nares microbiota of healthy children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Oral administration of pulverized Konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

A meta-analysis of probiotic efficacy for gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

The Antimicrobial Properties of Different Strains of Lactobacillus spp. Isolated from Kefir

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Hydrolyzed Konjac glucomannan suppresses IgE production in mice B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Inhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Immune stimulation and improved infection resistance in European sea bass (Dicentrarchus labrax) fed mannan oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Isolation, purification and partial characterization of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Probiotic bacteria as biological control agents in aquaculture

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

Effect of probiotics on the treatment of children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

What is the pathogenesis of acne?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0040

21 January 2018

Identifiers

DOI

10.3920/BM2013.0040

1 reference

6 August 2017

1 reference